Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By https://minarghz214364.loginblogin.com/43912990/tirzepatide-a-promising-new-treatment-for-obesity